Overview

ViiV Healthcare is a specialist pharmaceutical company focused solely on HIV treatment and prevention. Founded by GSK and Pfizer in 2009, with Shionogi joining in 2012, our goal is to end the HIV epidemic. We develop innovative medicines, work with partners to advance research, fight stigma, improve access, and support local organisations. ViiV Healthcare remains committed until HIV and AIDS are eradicated.

Position summary

This is a senior, high-impact global role with scale and visibility. The VP, Global Commercial Lead – HIV will own the end-to-end commercial agenda for one of our HIV assets, designing and delivering an ambitious, evidence-led strategy that protects and grows a global portfolio exceeding £5bn annual sales. You will lead a matrixed Product Commercialisation Team to execute outstanding operational delivery, financial stewardship and a transformational digital-first marketing model that sets the industry standard for mature assets.

Why this role

This asset is a major global HIV medicine — mature, widely used and commercially significant. This role offers a rare chance to shape long-term stewardship, defend value against competitive and pricing pressures, and create an industry-leading digital & data-driven marketing operating model that elevates HCP and patient engagement at scale.

Key responsibilities and scope

·       Strategy & portfolio stewardship

·       Own and drive an ambitious global product strategy and 3–5 year roadmap across formulations and combinations, fully aligned with ViiV strategy.

·       Translate clinical evidence, competitive dynamics and market access realities into decisive lifecycle actions to maximise long-term value.

·       Commercial leadership & cross-functional delivery

·       Lead the global Product Commercialisation Team (PCT) — Marketing, Market Access, Medical, Insights, Finance, Comms, Supply Chain, Legal/Compliance — to deliver ambitious business goals and exceptional customer experience.

·       Partner with R&D & Medical to ensure evidence generation and clinical lifecycle strategy optimally support commercial priorities.

·       Own launch/readiness plans for any new formulations/indications, ensuring robust sequencing and execution.

·       Create an industry-leading digital marketing model

·       Design and implement a cutting-edge, digital-first omnichannel approach that becomes the benchmark for mature assets.

·       Leverage CRM, advanced analytics, RWE and AI-enabled tech to personalise engagement, optimise resource allocation and measure meaningful clinical and commercial outcomes.

·       Rapidly pilot, scale and iterate innovative digital solutions to accelerate adoption, influence guidelines and improve patient outcomes.

·       Commercial operations & financial accountability

·       Own P&L, forecasting and performance reporting (in partnership with Finance); drive clear tactical and strategic interventions to meet revenue, margin and return targets.

·       Define pricing, contracting and access strategies with Market Access and Legal to protect sustainability while expanding patient access.

·       Collaborate with Supply Chain to optimise CoGS, secure supply continuity and drive operational efficiencies.

·       People & stakeholder leadership

·       Build, develop and inspire a high-performing global commercial organisation; attract and retain top talent.

·       Influence and align regional affiliates, global functions and external stakeholders to deliver a cohesive global strategy.

·       Represent ViiV externally with credibility and integrity — engaging clinicians, payers, partners and communities.

Deliverables and success measures

·       Commercial impact

·       Deliver agreed revenue, margin and P&L targets and meet or exceed the approved 3‑year sales ambition.

·       Protect or grow market share in priority markets; mitigate competitive erosion through lifecycle initiatives.

·       Digital transformation

·       Launch an industry-leading omnichannel/digital engagement model with clear KPIs (reach, engagement, adoption, guideline influence) and demonstrated ROI within 12–18 months.

·       Use RWE and digital analytics to show measurable improvements in prescribing behaviour, guideline uptake and patient outcomes.

·       Strategic and operational delivery

·       Deliver a clear global strategic plan and prioritized roadmap within the first 100 days; hit defined quarterly milestones thereafter.

·       Improve forecasting accuracy, ensure supply resilience, and meet CoGS optimisation targets while maintaining full compliance.

·       Evidence & access

·       Ensure evidence-generation (RWE, outcomes studies) is aligned to commercial needs and supports reimbursement and formulary success in priority markets.

·       Achieve agreed access metrics in key countries to sustain patient benefit and commercial viability.

Required experience and qualifications

·       Minimum 12+ years progressive commercial experience in pharma/biotech with demonstrated P&L ownership and success managing a high-value product/portfolio, ideally at a mature/late-stage lifecycle.

·       Experience leading global, matrixed, cross-functional teams and delivering complex multi-region programmes.

·       Experience in digital/omnichannel marketing, CRM, data-driven engagement and analytics with demonstrable commercial impact.

·       Experience partnering with R&D/Medical and Market Access to align evidence generation to commercial priorities.

·       Operational experience in forecasting, supply coordination, pricing/access negotiations and launch readiness.

·       Experience representing assets to HCPs, payers and external partners.

·       Degree in life sciences, business or related discipline.

Preferred qualifications

·       MBA or advanced degree.

·       Direct HIV/ARV experience, ideally with integrase inhibitors

·       Demonstrated success managing mature portfolios facing generic/commercial pressure and sustaining product value.

·       Deep knowledge of global market access, reimbursement and pricing frameworks across major markets.

·       Proven experience deploying CRM, RWE and advanced analytics at scale; familiarity with digital health/AI-enabled marketing tools.

·       Comfortable in complex matrix organisations and leading virtual, geographically dispersed teams.

·       Track record of building enterprise capability and inspiring teams to deliver stretch outcomes.